TheEdgeResearch
Home / Stocks / NSHSF

NanoSphere Health Sciences Inc. (NSHSF)

OTC Healthcare Biotechnology
$0.01 ▲ +0.00%
Market Cap
$102,752
Sector
Healthcare
Industry
Biotechnology
Beta
0.68
52-Wk Range
0.0041-0.02
CEO
Michael Alexander Iverson
Country
CA
Currency
USD

NanoSphere Health Sciences Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $102,752. On trailing twelve-month figures it carries a trailing P/E of -1.79, a net margin of 0.0%. Its beta of 0.68 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.79
Price / Sales
0.00
Price / Book
-0.11
EV / EBITDA
-0.95
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.04
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2009-10-08
Headquarters
Vancouver, BC, CA
About NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. operates as a nano-biotechnology enterprise, concentrating on the provision of biologically active compounds throughout both the United States and Canada. Its principal offering is the NanoSphere Deliver System, an advanced platform that leverages nanotechnology to enhance the biological absorption of supplements, nutraceuticals, and non-prescription drugs. This innovative system serves various industries, including cannabis, pharmaceuticals, and animal health. Established in 2005, the company maintains its corporate headquarters in Vancouver, Canada.

Comparable companies

NanoSphere Health Sciences Inc. is most often compared with the following Healthcare names:

BETRFBIXTBVAXFCHMMFCPMVCUBTGLWLFQNNTFTHERTXTM
More research on NSHSF
NSHSF technical analysis NSHSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →